Pediatric Annals (Pediatr Ann)

Publisher: Slack

Journal description

Pediatric Annals is America's most widely read journal for continuing education in the field of pediatrics. Each monthly issue provides a thorough, practical review of a single topic in pediatrics, carefully chosen by an editorial board composed of the leading pediatricians in the United States. Three credit hours in Category 1 for the Physician's Recognition Award of the AMA are offered for the successful completion of a CME quiz.

Current impact factor: 0.29

Impact Factor Rankings

2015 Impact Factor Available summer 2015
2013 / 2014 Impact Factor 0.288
2012 Impact Factor 0.303
2011 Impact Factor 0.484
2010 Impact Factor 0.503
2009 Impact Factor 0.369
2008 Impact Factor 0.541
2007 Impact Factor 0.724
2006 Impact Factor 0.741
2005 Impact Factor 0.383
2004 Impact Factor 0.374
2003 Impact Factor 0.318
2002 Impact Factor 0.223
2001 Impact Factor 0.383
2000 Impact Factor 0.739
1999 Impact Factor 0.459
1998 Impact Factor 0.355
1997 Impact Factor 0.31

Impact factor over time

Impact factor

Additional details

5-year impact 0.40
Cited half-life 8.40
Immediacy index 0.06
Eigenfactor 0.00
Article influence 0.13
Website Pediatric Annals website
Other titles Pediatric annals
ISSN 0090-4481
OCLC 1772141
Material type Periodical
Document type Journal / Magazine / Newspaper

Publisher details


  • Pre-print
    • Author cannot archive a pre-print version
  • Post-print
    • Author cannot archive a post-print version
  • Restrictions
    • 12 months embargo
  • Conditions
    • On Institutional Repositories
    • Publisher's version/PDF cannot be used
    • NIH authors may deposit in PubMed Central after 12 months
    • Must link to publisher version
  • Classification
    ‚Äč white

Publications in this journal

  • Pediatric Annals 07/2015; 44(7):278-9. DOI:10.3928/00904481-20150710-07
  • [Show abstract] [Hide abstract]
    ABSTRACT: Eczema is one of the most common skin conditions of childhood. Patients with eczema suffer in a chronic cycle of itch, scratch, and inflammation. For children with severe eczema, constant itching and scratching can have many consequences including skin infections, behavioral issues, and sleep problems. Parents often find themselves searching for a trigger for their child's eczema flare, and after they have switched detergents, applied a thick moisturizer and topical steroids, and removed all wool clothing from their child's wardrobe, they wonder, "Could food allergies be playing a role?" [Pediatr Ann. 2015;44(7):265-267.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 07/2015; 44(7):265-7. DOI:10.3928/00904481-20150710-04
  • Pediatric Annals 07/2015; 44(7):257-64. DOI:10.3928/00904481-20150710-03
  • [Show abstract] [Hide abstract]
    ABSTRACT: Severe combined immunodeficiency disorders (SCID) are a group of primary immunodeficiencies resulting from any one of a diverse group of mutations impacting T-cell development. SCID is diagnosed and classified through assessment of the lymphocyte subset(s) affected and by the mechanisms responsible for the primary immune defect. Regardless of the genetics involved, patients invariably succumb to an early death without medical intervention. In the past, patients were primarily identified either by previous family history, physical manifestations, or after the onset of symptoms. However, the introduction of newborn screening for SCID has allowed the pediatrician to identify these patients at a much earlier age, greatly improving their survival. Currently, 23 states include SCID testing for T-cell deficiencies in their newborn screening platform. Protocols for confirmatory testing and medical intervention after a positive screen vary slightly from state-to-state. However, the standard curative treatment remains stem cell transplantation, although depending on the genetic cause of the disease, enzyme replacement and gene therapy may also be considered. [Pediatr Ann. 2015;44(7):e181-e187.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 07/2015; 44(7):e181-7. DOI:10.3928/00904481-20150710-12
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pediatric acute lymphoblastic leukemia is the most common childhood cancer. Although the appearance of the disease is often quite dramatic, there are many patients who present much more indolently, creating a diagnostic dilemma for the primary care pediatrician. The appropriate diagnostic work-up assesses the initial extent of disease and stability of a patient, and provides information that is important for risk stratification. Such information includes patient age and white blood cell count at diagnosis, leukemia immunophenotype, presence or absence of extramedullary disease, and blast cytogenetic abnormalities. After therapy is initiated, the response of the disease to treatment is key for predicting outcomes. Altogether, this information is used to guide overall treatment intensity. Chemotherapy is administered in sequential blocks or phases, and lasts for several years. In general, outcomes are excellent and the majority of patients survive, but there are still subsets of patients who do not fare as well, either due to resistant or recurrent disease, or due to long-term and late effects of therapy. [Pediatr Ann. 2015;44(7):e168-e174.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 07/2015; 44(7):e168-74. DOI:10.3928/00904481-20150710-10
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abnormal vaginal bleeding in a postmenarchal adolescent patient is most often related to dysfunctional uterine bleeding. However, there are other potential etiologies, including hematologic disorders, infections, and oncologic problems. We present a 12-year-old girl who presented with prolonged vaginal bleeding and was ultimately diagnosed with rhabdomyosarcoma. In this article, we discuss the approach to a patient with vaginal bleeding along with a more in-depth review of risk stratification in rhabdomyosarcoma, including treatment options such as chemotherapy, surgery, and radiation therapy. [Pediatr Ann. 2015;44(7):e164-e167.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 07/2015; 44(7):e164-7. DOI:10.3928/00904481-20150710-09
  • [Show abstract] [Hide abstract]
    ABSTRACT: Neonatal thrombocytopenia has a broad range of possible etiologies. In this review, an asymptomatic newborn infant was found to have severe thrombocytopenia on laboratory testing for limited sepsis evaluation. The differential diagnosis for thrombocytopenia in the newborn period is discussed, along with recommendations for initial evaluation and follow up of isolated thrombocytopenia in an otherwise well-appearing infant. The clinician should be aware of findings associated with unusual causes of thrombocytopenia that should prompt additional evaluation in the nursery or in the general pediatrician's office. In this illustrative case, a high index of suspicion allowed early diagnosis of Wiskott-Aldrich syndrome and prompt curative therapy by stem cell transplant. [Pediatr Ann. 2015;44(7):e175-e180.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 07/2015; 44(7):e175-80. DOI:10.3928/00904481-20150710-11
  • Pediatric Annals 07/2015; 44(7):270-2. DOI:10.3928/00904481-20150710-05
  • Pediatric Annals 07/2015; 44(7):251-2. DOI:10.3928/00904481-20150710-01
  • Pediatric Annals 07/2015; 44(7):255-6. DOI:10.3928/00904481-20150710-02
  • Pediatric Annals 07/2015; 44(7):273-6. DOI:10.3928/00904481-20150710-06
  • [Show abstract] [Hide abstract]
    ABSTRACT: Anemia is a common problem in the neonatal period. Presenting symptoms may suggest numerous possible diagnoses ranging from anemia seen as a normal part of development to anemia due to critical pathology. An illustrative case is presented to highlight the appropriate evaluation of the neonate with significant anemia. Several important features of the evaluation of neonatal anemia are highlighted. The constellation of signs and symptoms that occur in conjunction with the anemia are critical for the evaluation. The evaluation should be performed in a step-wise process that starts by eliminating common causes of anemia. Manual review of the peripheral blood smear with a hematologist can be helpful. [Pediatr Ann. 2015;44(7):e159-e163.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 07/2015; 44(7):e159-63. DOI:10.3928/00904481-20150710-08
  • [Show abstract] [Hide abstract]
    ABSTRACT: A 14-year-old boy presented with months of severe widespread musculoskeletal pain. He was profoundly fatigued and unable to attend school. Laboratory evaluation, including complete blood count, comprehensive metabolic panel, inflammatory markers, and thyroid function, was unrevealing. Physical examination was also normal except for multiple tender points. The patient was diagnosed with juvenile primary fibromyalgia syndrome and referred for multidisciplinary treatment including physical therapy, exercise, and counseling, and his daily functioning gradually improves. Juvenile fibromyalgia is a complex syndrome that often severely limits patients' activities and can impede normal adolescent development. Effective treatment requires an understanding of the biologic, psychologic, and social factors contributing to the perpetuation of chronic pain. The author reviews the diagnostic criteria, pathophysiology, and treatment of juvenile fibromyalgia. Medications, particularly antidepressants and anticonvulsants, can be useful adjuncts to therapy. However, multimodal pain management including intensive physical therapy, exercise, counseling, and sleep hygiene is most effective in treating fibromyalgia. [Pediatr Ann. 2015;44(6):e136-e141.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 06/2015; 44(6):e136-e141. DOI:10.3928/00904481-20150611-08
  • Pediatric Annals 06/2015; 44(6):216-217. DOI:10.3928/00904481-20150611-01
  • [Show abstract] [Hide abstract]
    ABSTRACT: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by the presence of antinuclear antibodies and other autoantibodies, as well as a clinical course that is characterized by flares and remissions. The clinical presentation is diverse, ranging from a mild disease characterized by rash and arthritis to a severe life-threatening disease involving multiple organs. Approximately 25% of children with SLE have neuropsychiatric manifestations of SLE, which are a major cause of morbidity and mortality. Neuropsychiatric symptoms may be the initial presentation of SLE in children. The mortality rate is relatively low, but morbidity may be significant and permanent damage can occur. This article discusses the importance, known pathophysiologic mechanisms, clinical approach, and evidence-based therapeutic options for the diagnosis and management of neuropsychiatric lupus erythematosus in children and adolescents. [Pediatr Ann. 2015;44(6):e153-e158.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 06/2015; 44(6):e153-e158. DOI:10.3928/00904481-20150611-11
  • Pediatric Annals 06/2015; 44(6):236-237. DOI:10.3928/00904481-20150611-05
  • [Show abstract] [Hide abstract]
    ABSTRACT: A 15-year-old girl presented with knee pain, associated with a positive antinuclear antibody (ANA). She denied joint swelling or morning stiffness and remained physically active despite the pain. A physical examination was unremarkable except for articular hypermobility. Laboratory results were also unremarkable. Therefore, the positive ANA was determined to be nonspecific, and not concerning. In the evaluation of children with musculoskeletal complaints, unusual rash, or fatigue, an ANA assessment is frequently considered. When is this test most likely to be useful? What is the appropriate follow up for a positive result? Which results are concerning for an autoimmune process? This article reviews the literature to address these practical concerns. Understanding the indications for ordering an ANA, and the correct interpretation of a positive ANA, may reduce unnecessary referrals and costly tests. Moreover, the misperception that a positive ANA indicates a rheumatologic disease can cause significant patient and parental anxiety. [Pediatr Ann. 2015;44(6):e131-e135.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 06/2015; 44(6):e131-e135. DOI:10.3928/00904481-20150611-07
  • Pediatric Annals 06/2015; 44(6):238-239. DOI:10.3928/00904481-20150612-06
  • Pediatric Annals 06/2015; 44(6):232-234. DOI:10.3928/00904481-20150611-04
  • Pediatric Annals 06/2015; 44(6):218-222. DOI:10.3928/00904481-20150611-02